Safety of dabigatran as an anticoagulant: a systematic review and meta-analysis
Y Zhou, Z Yao, L Zhu, Y Tang, J Chen… - Frontiers in …, 2021 - frontiersin.org
Background: Dabigatran is a univalent low-molecular-weight direct thrombin inhibitor which
was developed as an alternative to vitamin K antagonists (VKAs). However, the safety of …
was developed as an alternative to vitamin K antagonists (VKAs). However, the safety of …
Extraction methods and compositions of polyphenols in Shanxi aged vinegar
J Liu, J Wang, G Shen, H Meng, J Zhou, M Xia… - … of Chromatography A, 2023 - Elsevier
The extraction, purification, qualification, and quantification of polyphenols (PPs) in vinegar
are challenging owing to the complex matrix of vinegar and the specific physicochemical …
are challenging owing to the complex matrix of vinegar and the specific physicochemical …
Development and validation of LC–MS/MS method for simultaneous determination of dabigatran etexilate and its active metabolites in human plasma, and its …
Dabigatran is a direct thrombin inhibitor widely used for preventing various thrombotic
events. Although there are several established LC–MS/MS based methods for quantification …
events. Although there are several established LC–MS/MS based methods for quantification …
[引用][C] Response to: Time frame for withholding direct thrombin inhibitor therapy before neurosurgery
Z Pennington, D Lubelski… - Clinical neurology and …, 2020 - pubmed.ncbi.nlm.nih.gov
Response to: Time frame for withholding direct thrombin inhibitor therapy before
neurosurgery Response to: Time frame for withholding direct thrombin inhibitor therapy …
neurosurgery Response to: Time frame for withholding direct thrombin inhibitor therapy …
[引用][C] Extremely elevated international normalized ratio in a patient using dabigatran etexilate: a case report
J Kim, Y Jung, J Oh, SW Han… - Journal of …, 2023 - Korean Neurocritical Care Society